Associate Director, Global Program ManagementResponsibilities: Drive the planning and execution of new product development from concept through registrational clinical studies.

Associate Director of Project Management, Pipeline and Commercial PlanningResponsibilities: Drive operational planning and execution related to progression of drug and drug/device products from pre-clinical stage to phase 3. Primary responsibilities include: 1) identifying target molecules to optimize the Xerisol and Xeriject Technology Platform and 2)management and coordination of activities for multiple drug development candidates/projects.

Primary leadership for development of clinical diagnostic medical devices from early stage development through product launch. Develop tools and processes to improve the effectiveness and productivity of the TPM product development pipeline. Build strong business partnerships between Abbott and TPM’s based on transparency, mutual respect and shared accountability.

Primary leadership in the development and implementation of a R&D portfolio management system. Orchestrate vaccine development teams through corporate governance stage gates. Mentor direct reports on best practices for portfolio management.

Primary leadership for cross-functional product development teams in the food/beverage and life sciences industries. Lead cross-functional teams to execute and deliver high quality products on time and at lower costs through the implementation and execution of professional project management practices.- Leading a cross-function team at a top 10 food/beverage company in establishing Proof-of-Concept for a new sports nutrition product to enhance exercise performance.- Led a cross-functional R&D team at Fortune 500 healthcare company in the development of the strategy and test methods for all solution based pharmaceutical products to comply with new metal impurity guidance from the US Pharmacopeia (USP <232>).- Developed the product development process by which a phase 1 hormone replacement therapy drug was fast-tracked to phase 3 clinical trials within 12 months for a Fortune 500 Pharmaceutical Company.- Coordinated the identification of 188 clinical trials, the retrieval of their primary data, translation of the data into English, and incorporation into an integrated database in support of the periodic update of a Company Core Data Sheet for a Fortune 500 Pharmaceutical company's top neuroscience drug.- Led a cross-functional product development team at a Fortune 500 Food/Beverage Company to develop a functional food ingredient for an iconic brand of beverage products, which obtained GRAS status in November 2010. (see Publications)- Developed a wiki site on a SharePoint network to provide a user-friendly body of knowledge on the pharmaceutical and medical device industries for consultants with little or no experience in these industries. Replicated the wiki site approach for other knowledge areas including SharePoint collaboration tools.

Primary leadership force for a team of young academic scientists and engineers to innovate new rapid diagnostic tests for the developing world. Educate the next generation of engineers, physicians and scientists about the process by which medical devices are designed, developed and marketed through hands-on experience and formal course work.• Propelled research team to leverage intellectual property and develop low cost (less than $1.00 per test) rapid point of care diagnostics to screen infants for HIV (see Publications).• Creative force behind launching web communication content for CIGHT research center (www.cight.northwestern.edu) from scratch.• Modernized course materials and taught an undergraduate engineering course resulting in student satisfaction ratings going from 61% favorable to 88% favorable.

Champion the mutual benefits and values of the NU engineering school to industrial partners in the biomedical business sector. Drive industry awareness of NU engineering value through FastScience® product sampling then forge relationships to grow corporate investment in faculty research.• Secured corporate sponsorship of Biomedical Engineering Society 2006 Annual Conference.• Driving force behind expansion of corporate participation in the FastScience® program by 2 fold in 12 months.• Orchestrated a financial business model for FastScience® program ensuring federal regulatory compliance and streamlined accounting/project tracking• Championed Northwestern University brand awareness through creative redesign of FastScience® brochures and marketing materials.

Abbott Hospital Products became Hospira in 2004.Create innovative corporate strategies to pursue generic biological pharmaceuticals. Orchestrate core chemistry support (CMC section of FDA drug registration) in launching new branded or generic parenteral drugs. Direct and motivate teams of scientists to develop, characterize and validate analytical tests that assure drug purity, potency and safety.Awarded Hospira Senior Development Scientist of the Year 2004 for these areas of accomplishment:• Technical leadership force in due diligence selection of two candidate drugs to launch Hospira Inc. into biogeneric pharmaceutical market.• Advocated Hospira corporate strategy on biogeneric pharmaceuticals to the Generic Pharmaceutical Association (GPhA), via white paper document, as part of GPhA briefing to the FDA.• Spearheaded core chemistry support for Hospira product portfolio expansion resulting in three generic drug submissions to the FDA within one year.• Bolstered Hospira corporate strategy by authoring USP test method monographs for injectable fluconazole making Hospira analytical methodology an industry standard.

Abbott Hospital ProductsOrchestrate core chemistry support (CMC section of FDA drug registration) in launching new branded or generic parenteral drugs. Direct and motivate teams of scientists to develop, characterize and validate analytical tests that assure drug purity, potency and safety.